The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Androgen receptor coregulators and their involvement in the development and progression of prostate cancer
Abstract
The androgen receptor signaling axis plays an essential role in the development, function and homeostasis of male urogenital structures including the prostate gland although the mechanism by which the AR axis contributes to the initiation, progression and metastatic spread of prostate cancer remains somewhat enigmatic. A number of molecular events have been proposed to act at the level of the AR and associated coregulators to influence the natural history of prostate cancer including deregulated expression, somatic mutation, and post‐translational modification. The purpose of this article is to review the evidence for deregulated expression and function of the AR and associated coactivators and corepressors and how such events might contribute to the progression of prostate cancer by controlling the selection and expression of AR targets. © 2006 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Recurrent Fusion of TMPRSS2 and ETS Transcription Factor Genes in Prostate Cancer
Tomlins, S. A., Rhodes, D. R., Perner, S., Dhanasekaran, S. M., Mehra, R., Sun, X.-W., Varambally, S., Cao, X., Tchinda, J., Kuefer, R., et al. (2005) · Science · doi:10.1126/science.1117679 · Cited by 3,846
The development of androgen-independent prostate cancer.
Feldman, B. J., & Feldman, D. (2001) · Nature reviews. Cancer · doi:10.1038/35094009 · Cited by 2,326
Molecular determinants of resistance to antiandrogen therapy
Chen, C. D., Welsbie, D. S., Tran, C., Baek, S. H., Chen, R., Vessella, R., Rosenfeld, M. G., & Sawyers, C. L. (2004) · Nature Medicine · doi:10.1038/nm972 · Cited by 2,278
In vivo amplification of the androgen receptor gene and progression of human prostate cancer
Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinänen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., & Kallioniemi, O.-P. (1995) · Nature Genetics · doi:10.1038/ng0495-401 · Cited by 1,484
Scher, H. I., & Sawyers, C. L. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.4777 · Cited by 1,025
Yu, Y. P., Landsittel, D., Jing, L., Nelson, J., Ren, B., Liu, L., McDonald, C., Thomas, R., Dhir, R., Finkelstein, S., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.05.158 · Cited by 758
The Roles of Androgen Receptors and Androgen-Binding Proteins in Nongenomic Androgen Actions
Heinlein, C. A., & Chang, C. (2002) · Molecular Endocrinology · doi:10.1210/me.2002-0070 · Cited by 568
A New First Step in Activation of Steroid Receptors
Davies, T. H., Ning, Y.-M., & Sánchez, E. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.c100531200 · Cited by 427
Structural basis of androgen receptor binding to selective androgen response elements
Shaffer, P. L., Jivan, A., Dollins, D. E., Claessens, F., & Gewirth, D. T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0401123101 · Cited by 400
Nuclear receptors: integration of multiple signalling pathways through phosphorylation
Rochette-Egly, C. (2003) · Cellular Signalling · doi:10.1016/s0898-6568(02)00115-8 · Cited by 291
Research works printed but not linked: 250
- 10.1210/mend-2-12-1265 · DOI · Paper page
- 10.1210/edrv-8-3-338 · DOI · Paper page
- 10.1083/jcb.96.6.1662 · DOI · Paper page
- 10.1111/j.1432-0436.1983.tb01317.x · doi:10.1111/j.1432-0436.1983.tb01317.x
- 10.1210/endo-107-6-1767 · DOI
- Cunha GR, 1984, Androgenic effects upon prostatic epithelium are mediated via trophic influences from stroma, Prog Clin Biol Res, 145, 81
- 10.1210/endo-128-6-3293 · DOI
- 10.1111/j.1432-0436.2005.00047.x · doi:10.1111/j.1432-0436.2005.00047.x
- 10.3322/canjclin.55.1.10 · DOI · Paper page
- Ruizeveld de Winter JA, 1994, Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer, Am J Pathol, 144, 735
- 10.1016/S0022-5347(17)37389-5 · DOI
- 10.1002/1097-0142(19910615)67:12<3057::AID-CNCR2820671221>3.0.CO;2-S · DOI
- Henshall SM, 2001, Altered expression of androgen receptor in the malignant epithelium and adjacent stroma is associated with early relapse in prostate cancer, Cancer Res, 61, 423
- 10.1002/pros.20154 · DOI
- Linja MJ, 2001, Amplification and overexpression of androgen receptor gene in hormone‐refractory prostate cancer, Cancer Res, 61, 3550
- Koivisto P, 1997, Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer, Cancer Res, 57, 314
- 10.1677/erc.1.00525 · DOI · Paper page
- 10.1210/jc.2002-022038 · DOI · Paper page
- 10.1200/JCO.2002.10.018 · DOI · Paper page
- 10.1002/pros.2990220103 · DOI
- 10.1002/(SICI)1097-0045(199603)28:3<162::AID-PROS3>3.0.CO;2-H · DOI
- Tilley WD, 1996, Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence, Clin Cancer Res, 2, 277
- Taplin ME, 1999, Selection for androgen receptor mutations in prostate cancers treated with androgen antagonist, Cancer Res, 59, 2511
- 10.1056/NEJM199505253322101 · DOI · Paper page
- Buchanan G, 2001, Collocation of androgen receptor gene mutations in prostate cancer, Clin Cancer Res, 7, 1273
- Culig Z, 1994, Androgen receptor activation in prostatic tumor cell lines by insulin‐like growth factor‐I, keratinocyte growth factor, and epidermal growth factor, Cancer Res, 54, 5474
- 10.1038/bjc.1998.142 · doi:10.1038/bjc.1998.142
- 10.1073/pnas.0408925102 · DOI · Paper page
- Shibata H, 1997, Role of co‐activators and co‐repressors in the mechanism of steroid/thyroid receptor action, Recent Prog Horm Res, 52, 141
- 10.1016/S0959-437X(99)80021-5 · DOI · Paper page
- 10.1210/er.20.3.321 · DOI
- 10.1002/1097-0045(20001001)45:2<124::AID-PROS6>3.0.CO;2-7 · doi:10.1002/1097-0045(20001001)45:2<124::aid-pros6>3.0.co;2-7
- 10.1093/emboj/19.3.359 · DOI · Paper page
- 10.1074/jbc.M306576200 · DOI
- 10.1016/S0002-9440(10)64422-7 · DOI
- 10.1128/MCB.25.4.1425-1436.2005 · DOI
- 10.1128/MCB.25.6.2200-2215.2005 · DOI
- 10.1002/(SICI)1521-1878(199810)20:10<860::AID-BIES12>3.0.CO;2-S · doi:10.1002/(sici)1521-1878(199810)20:10<860::aid-bies12>3.0.co;2-s
- 10.1074/jbc.M111975200 · DOI
- 10.1016/S0021-9258(18)52466-2 · DOI · Paper page
- 10.1074/jbc.270.13.7341 · DOI · Paper page
- 10.1210/me.9.2.208 · DOI · Paper page
- 10.1016/S1096-7192(02)00009-4 · DOI
- 10.1093/hmg/ddh181 · DOI
- 10.1677/jme.1.01723 · DOI
- 10.1093/nar/21.5.1125 · DOI
- 10.1042/bj3410515 · DOI
- 10.1126/science.2115209 · DOI · Paper page
- 10.1038/nsb0595-386 · DOI
- 10.1016/0960-0760(93)90338-W · DOI
- 10.1074/jbc.275.16.12290 · DOI
- 10.1210/me.13.9.1558 · DOI
- 10.1074/jbc.275.16.12298 · DOI
- 10.1016/S1097-2765(02)00471-9 · DOI · Paper page
- 10.1016/S0960-0760(00)00154-0 · DOI
- 10.1196/annals.1329.068 · DOI
- 10.1074/jbc.M302460200 · DOI · Paper page
- 10.1210/me.9.5.605 · DOI · Paper page
- 10.1074/jbc.M204131200 · DOI · Paper page
- 10.1128/MCB.23.23.8563-8575.2003 · DOI · Paper page
- 10.1074/jbc.M004571200 · DOI · Paper page
- 10.1073/pnas.081565498 · DOI · Paper page
- 10.1038/39645 · DOI · Paper page
- 10.1038/375377a0 · DOI · Paper page
- 10.1074/jbc.M202809200 · DOI
- 10.1016/0303-7207(96)03800-2 · DOI
- 10.1016/S0021-9258(18)98349-3 · DOI
- Grad JM, 1999, Multiple androgen response elements and a Myc consensus site in the androgen receptor (AR) coding region are involved in androgen‐mediated up‐regulation of AR messenger RNA, Mol Endocrinol, 13, 1896, 10.1210/mend.13.11.0369 · DOI
- 10.1126/stke.2122003re15 · DOI
- 10.1158/0008-5472.CAN-06-0411 · DOI
- 10.1128/MCB.23.1.104-118.2003 · DOI
- 10.1210/er.18.3.306 · DOI
- 10.1074/jbc.273.13.7358 · DOI
- 10.1074/jbc.273.49.32973 · DOI · Paper page
- 10.1016/j.canlet.2004.12.037 · DOI
- 10.1126/science.7761850 · DOI · Paper page
- 10.1210/me.7.1.4 · DOI · Paper page
- 10.1074/jbc.271.23.13468 · DOI
- 10.1016/0962-8924(95)80013-7 · DOI
- 10.1083/jcb.114.4.609 · DOI · Paper page
- 10.1042/bse0400041 · DOI · Paper page
- 10.1016/S0968-0004(01)01834-5 · DOI
- 10.1016/S0955-0674(97)80066-X · DOI · Paper page
- 10.1016/S0092-8674(03)00934-6 · DOI · Paper page
- 10.1074/jbc.274.29.20229 · DOI · Paper page
- 10.1074/jbc.M403117200 · DOI
- 10.1210/mend.16.4.0798 · DOI
- 10.1091/mbc.01-10-0513 · DOI
- 10.1073/pnas.94.16.8485 · DOI · Paper page
- 10.1074/jbc.M205220200 · DOI
- 10.1093/emboj/cdg585 · DOI
- 10.1074/jbc.273.48.31853 · DOI · Paper page
- 10.1128/MCB.21.14.4614-4625.2001 · DOI
- 10.1074/jbc.275.13.9308 · DOI
- 10.1074/jbc.M108255200 · DOI · Paper page
- Park JJ, 2000, Breast cancer susceptibility gene 1 (BRCA1) is a coactivator of the androgen receptor, Cancer Res, 60, 5946
- 10.1073/pnas.190353897 · DOI
- 10.1128/MCB.24.24.10529-10541.2004 · DOI
- 10.1073/pnas.1132020100 · DOI
- 10.1128/MCB.19.12.8383 · DOI · Paper page
- Nishimura K, 2003, Modulation of androgen receptor transactivation by gelsolin: a newly identified androgen receptor coregulator, Cancer Res, 63, 4888
- 10.1074/jbc.273.47.31528 · DOI
- 10.1210/mend.14.1.0408 · DOI
- 10.1038/sj.onc.1204489 · DOI
- 10.1074/jbc.M000660200 · DOI · Paper page
- Janne OA, 2000, Androgen‐receptor‐interacting nuclear proteins, Biochem Soc Trans, 28, 401, 10.1042/bst0280401 · DOI
- 10.1074/jbc.274.6.3700 · DOI
- 10.1074/jbc.274.12.8316 · DOI · Paper page
- 10.1074/jbc.M206061200 · DOI
- 10.1074/jbc.274.25.17599 · DOI · Paper page
- 10.1073/pnas.93.10.4948 · DOI · Paper page
- 10.1074/jbc.274.13.8570 · DOI · Paper page
- 10.1074/jbc.274.48.34283 · DOI · Paper page
- 10.1074/jbc.M312563200 · DOI
- 10.1074/jbc.M106399200 · DOI
- 10.1074/jbc.274.32.22373 · DOI
- 10.1074/jbc.M408972200 · DOI
- 10.1210/endo.141.9.7680 · DOI
- 10.1126/science.277.5328.965 · DOI · Paper page
- 10.1016/S0092-8674(00)80516-4 · DOI · Paper page
- 10.1073/pnas.94.16.8479 · DOI · Paper page
- 10.1126/science.270.5240.1354 · DOI · Paper page
- 10.1074/jbc.272.44.27629 · DOI · Paper page
- 10.1210/mend.12.2.0065 · DOI · Paper page
- 10.1016/S0960-0760(00)00027-3 · DOI
- 10.1074/jbc.M009916200 · DOI
- 10.1038/38304 · DOI · Paper page
- 10.1038/383099a0 · DOI · Paper page
- 10.1101/gad.12.11.1638 · DOI · Paper page
- 10.1210/er.2004-0008 · DOI · Paper page
- 10.1016/S0960-0760(03)00222-X · DOI
- 10.1126/science.279.5351.703 · DOI · Paper page
- 10.1016/S0092-8674(03)00599-3 · DOI
- 10.1242/jcs.00734 · DOI
- Gregory CW, 2001, A mechanism for androgen receptor‐mediated prostate cancer recurrence after androgen deprivation therapy, Cancer Res, 61, 4315
- 10.1158/0008-5472.CAN-04-4076 · DOI
- 10.1054/bjoc.2001.2179 · DOI
- Debes JD, 2003, p300 in prostate cancer proliferation and progression, Cancer Res, 63, 7638
- 10.1002/path.1609 · DOI
- 10.1677/erc.1.00775a · DOI
- 10.1038/sj.onc.1206121 · DOI
- Nagata A, 1991, An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells, New Biol, 3, 959
- 10.1038/labinvest.3780254 · DOI
- Gasparotto D, 1997, Overexpression of CDC25A and CDC25B in head and neck cancers, Cancer Res, 57, 2366
- 10.1126/science.7667636 · DOI · Paper page
- 10.1002/ijc.21469 · DOI
- 10.1038/sj.onc.1206342 · DOI
- 10.1038/nature03452 · DOI · Paper page
- 10.1016/S0955-0674(99)80012-X · DOI · Paper page
- 10.1002/(SICI)1097-0045(19990615)40:1<14::AID-PROS2>3.0.CO;2-6 · doi:10.1002/(sici)1097-0045(19990615)40:1<14::aid-pros2>3.0.co;2-6
- Asch HL, 1996, Widespread loss of gelsolin in breast cancers of humans, mice, and rats, Cancer Res, 56, 4841
- Dosaka‐Akita H, 1998, Frequent loss of gelsolin expression in non‐small cell lung cancers of heavy smokers, Cancer Res, 58, 322
- Tanaka M, 1995, Gelsolin: a candidate for suppressor of human bladder cancer, Cancer Res, 55, 3228
- 10.1126/science.1848726 · DOI · Paper page
- 10.1073/pnas.95.15.8532 · DOI
- 10.1126/science.278.5336.294 · DOI · Paper page
- 10.1074/jbc.M401781200 · DOI
- Chang HC, 2005, In vitro gene expression changes of androgen receptor coactivators after hormone deprivation in an androgen‐dependent prostate cancer cell line, J Formos Med Assoc, 104, 652
- 10.1002/pros.10229 · DOI
- 10.1158/1078-0432.CCR-0990-3 · DOI
- Kasai M, 2003, The Group 3 LIM domain protein paxillin potentiates androgen receptor transactivation in prostate cancer cell lines, Cancer Res, 63, 4927
- 10.1002/pros.10262 · DOI
- 10.1210/me.2005-0324 · DOI · Paper page
- 10.1042/bj20031456 · DOI
- 10.1210/mend.11.6.0004 · doi:10.1210/mend.11.6.0004 · Paper page
- 10.1074/jbc.M206374200 · DOI · Paper page
- 10.1002/jcb.10757 · DOI
- 10.1016/S0090-4295(01)01117-7 · DOI
- 10.1073/pnas.0304146101 · DOI · Paper page
- 10.1038/35090585 · DOI · Paper page
- Magee JA, 2001, Expression profiling reveals hepsin overexpression in prostate cancer, Cancer Res, 61, 5692
- LaTulippe E, 2002, Comprehensive gene expression analysis of prostate cancer reveals distinct transcriptional programs associated with metastatic disease, Cancer Res, 62, 4499
- 10.1016/S1535-6108(02)00030-2 · DOI · Paper page
- 10.1002/mc.10018 · DOI · Paper page
- Welsh JB, 2001, Analysis of gene expression identifies candidate markers and pharmacological targets in prostate cancer, Cancer Res, 61, 5974
- 10.1016/j.molcel.2004.09.036 · DOI · Paper page
- 10.1074/jbc.274.52.37219 · DOI · Paper page
- 10.1210/me.2005-0298 · DOI
- 10.1128/MCB.23.6.2135-2150.2003 · DOI
- 10.1002/jcb.10653 · DOI · Paper page
- 10.1093/nar/26.1.234 · DOI
- Buchanan G, 2001, Mutations at the boundary of the hinge and ligand binding domain of the androgen receptor confer increased transactivation function, Mol Endocrinol, 15, 46, 10.1210/mend.15.1.0581 · DOI
- 10.1097/01.LAB.0000038924.67707.75 · DOI
- 10.1074/jbc.M008207200 · DOI
- 10.1023/A:1015531326689 · DOI · Paper page
- 10.1038/nsb0196-87 · DOI · Paper page
- 10.1038/76287 · DOI · Paper page
- 10.1210/me.2001-0281 · DOI
- 10.1210/me.2004-0190 · DOI
- 10.1016/0960-0760(92)90401-4 · DOI · Paper page
- 10.1210/me.2003-0436 · DOI
- 10.1002/pros.20191 · DOI
- 10.1210/me.2005-0231 · DOI
- 10.1210/me.2005-0134 · DOI
- 10.1074/jbc.M503850200 · DOI
- Truica CI, 2000, β‐Catenin affects androgen receptor transcriptional activity and ligand specificity, Cancer Res, 60, 4709
- Voeller HJ, 1998, β‐Catenin mutations in human prostate cancer, Cancer Res, 58, 2520
- Cronauer MV, 2005, Effects of WNT/β‐catenin pathway activation on signaling through T‐cell factor and androgen receptor in prostate cancer cell lines, Int J Oncol, 26, 1033
- 10.1093/oxfordjournals.jjco.a023188 · DOI
- Drobnjak M, 2000, Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone, Clin Cancer Res, 6, 1891
200 of 250 shown
Cited by
Locke, J. A., Guns, E. S., Lubik, A. A., Adomat, H. H., Hendy, S. C., Wood, C. A., Ettinger, S. L., Gleave, M. E., & Nelson, C. C. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5997 · Cited by 747
Molecular cell biology of androgen receptor signalling
Bennett, N. C., Gardiner, R. A., Hooper, J. D., Johnson, D. W., & Gobe, G. C. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.11.013 · Cited by 292
Brooke, G. N., Parker, M. G., & Bevan, C. L. (2008) · Oncogene · doi:10.1038/sj.onc.1210955 · Cited by 79
Allioli, N., Vincent, S., Vlaeminck‐Guillem, V., Decaussin‐Petrucci, M., Ragage, F., Ruffion, A., & Samarut, J. (2011) · The Prostate · doi:10.1002/pros.21340 · Cited by 47
Tgf-beta in the natural history of prostate cancer
Ahel, J. (2019) · Acta Clinica Croatica · doi:10.20471/acc.2019.58.01.17 · Cited by 30
Metadata
- Authors
- Chmelar, R., Buchanan, G., Need, E. F., Tilley, W., & Greenberg, N. M.
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2006-12-27
- Volume
- 120
- Issue
- 4
- Pages
- 719-733
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2010246016
- Cited by
- 255
- References
- 20
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- closed
- Funders
- National Cancer Institute (NMG) (CA73747, CA84296)
- National Health and Medical Research Council of Australia (WDT) (299048)
- US Department of Defense (W81XWH-04-1-0017)
- NHMRC CJ Martin Biomedical Fellowship
- Florey Adelaide Male Aging Study
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. https://app.cochat.ai/papers/10.1002/ijc.22365
- The paper
- Chmelar, R., Buchanan, G., Need, E. F., Tilley, W., & Greenberg, N. M. (2007). Androgen receptor coregulators and their involvement in the development and progression of prostate cancer. International Journal of Cancer. https://doi.org/10.1002/ijc.22365
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.